Skip to content
Peptide Spencer
Partner

Blend

Oxytocin / PT-141 / Kisspeptin

Custom strengths on request

Compounded medications are not FDA-approved.

What is in the vial

Blend calculator

This blend includes Oxytocin, which has no established dose basis for blend dosing. Confirm the plan with the pharmacist.

Each component at a glance

Oxytocin

These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.

  1. Start

    24 IU intranasal, single dose (healthy adult men)

    Human study

  2. Typical

    24 IU intranasal (standard dose in most healthy-adult studies)

    Human study

  3. Ceiling

    72 IU intranasal twice daily on every third day (FOXY, adults with FTD)

    Human study
Frequency
Twice daily in multi-week trials; mainly single doses in short studies
Route
Intranasal (the route with human trial data)
Course
24 weeks (longest trial, children and adolescents with autism)
Intranasal IU trial doses do not transfer to injection; the 10 mg vial holds at least 4,000 units, so never enter IU as mg.
Calculate this dose

Full dosing guide

PT-141

These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.

  1. Start

    1.75 mg subcutaneously per dose, abdomen or thigh, as needed

    Approved label

  2. Ceiling

    1.75 mg SC per dose, no titration; over 8 doses per month not recommended

    Approved label
Frequency
As needed, at least 45 min before activity; no more than one dose in 24 hours
Route
Subcutaneous, abdomen or thigh (autoinjector)
Course
Discontinue after 8 weeks if no improvement in symptoms
Contraindicated in uncontrolled hypertension or known cardiovascular disease; approved only for premenopausal women, and male trials used intranasal doses that do not convert to subcutaneous.
Calculate this dose

Full dosing guide

Kisspeptin

These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.

  1. Start

    150 nmol/h subcutaneous infusion (portable pump, soft cannula)

    Human study
Frequency
Once daily, 8 h on / 16 h off
Route
subcutaneous infusion (portable pump, soft cannula)
Course
12 days
150 nmol/h is an 8 h pump infusion rate in healthy men, not a bolus dose; the only SC bolus on record (women) was inert.
Calculate this dose

Full dosing guide

Get a quote

Custom strengths on request. Prices are quoted per clinic.